Document Detail

Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents.
MedLine Citation:
PMID:  10953285     Owner:  NLM     Status:  MEDLINE    
Squamous cell carcinoma (SCC) of the oral cavity is a multistep process, progressing through a series of discrete, irreversible and complementary alterations in genes that control cell growth, death, and differentiation. In the premalignant state, the oral mucosa progresses through various grades of epithelial dysplasia, with the potential to convert to SCC. Chemopreventive strategies are designed to suppress, reverse, or prevent the formation of premalignant lesions and their subsequent progression to SCC. In the present study, we determined the growth inhibitory effect of 21 chemopreventive agents in a cell culture model using normal, premalignant, and malignant human oral mucosal cell lines. There were significant differences in the growth inhibitory responses of these cell lines to selected retinoids and non-retinoid analogs. Among the retinoids tested, the synthetic retinamides, as a class, showed selective growth inhibition of both premalignant and malignant cells compared to normal human oral epithelial cells in culture. Within the retinamide class, 2CPR exhibited the greatest selectivity in the growth inhibition of premalignant and malignant cells. Among the non-retinoids analyzed, DFMO was a moderate to potent inhibitor of malignant and premalignant oral cell growth, respectively, and stimulated normal oral cell growth at low concentrations. Using this in vitro approach, we have identified several potential chemopreventive agents for oral cancer as selective growth inhibitors of premalignant ahd malignant human oral mucosa cells.
S M D'Ambrosio; R Gibson-D'Ambrosio; G E Milo; B Casto; G J Kelloff; V E Steele
Related Documents :
3008355 - Langerhans' cells, papillomaviruses and oesophageal carcinoma. a hypothesis.
2988275 - Invasive squamous cell carcinoma of the uterine cervix. ix. construction of a partial i...
21039745 - Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cel...
14612505 - Aberrant expression of t-plastin in sezary cells.
2479415 - Resistance to pyrazofurin and 6-azauridine in normal mc3t3-e1 murine osteoblasts.
2272145 - Entrapped, non-neoplastic adenohypophysiocytes in human pituitary adenomas.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Anticancer research     Volume:  20     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    2000 Jul-Aug
Date Detail:
Created Date:  2000-08-31     Completed Date:  2000-08-31     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  2273-80     Citation Subset:  IM    
Ohio State University School of Medicine and Public Health, Columbus, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetylcysteine / pharmacology
Anticarcinogenic Agents / pharmacology*
Cell Division / drug effects
Cell Line
Curcumin / pharmacology
Eflornithine / pharmacology
Mouth Mucosa / drug effects*
Mouth Neoplasms / pathology,  prevention & control*
Precancerous Conditions / pathology,  prevention & control*
Retinoids / pharmacology
Grant Support
Reg. No./Substance:
0/Anticarcinogenic Agents; 0/Retinoids; 458-37-7/Curcumin; 616-91-1/Acetylcysteine; 70052-12-9/Eflornithine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Time-dependent dephosphorylation through serine/threonine phosphatases is required for stable adhesi...
Next Document:  Longitudinal analysis of mammary cancer multiplicity in chemoprevention studies.